Go to:
Logótipo
You are here: Start > Publications > View > Factorial design as a tool for the optimization of plga nanoparticles for the co-delivery of temozolomide and o6-benzylguanine
Today is sunday
Programa de formação da Biblioteca para o primeiro semestre já está disponível
Publication

Factorial design as a tool for the optimization of plga nanoparticles for the co-delivery of temozolomide and o6-benzylguanine

Title
Factorial design as a tool for the optimization of plga nanoparticles for the co-delivery of temozolomide and o6-benzylguanine
Type
Article in International Scientific Journal
Year
2019
Authors
Maria João Ramalho
(Author)
FEUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page Without ORCID
Manuel A. N. Coelho
(Author)
FEUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Journal
Title: PharmaceuticsImported from Authenticus Search for Journal Publications
Vol. 11 No. 8
Pages: 1-18
ISSN: 1999-4923
Publisher: MDPI
Indexing
Other information
Authenticus ID: P-00R-1CV
Resumo (PT):
Abstract (EN): Poly(D,L-lactic-co-glycolic) (PLGA) nanoparticles (NPs) have been widely studied for several applications due to their advantageous properties, such as biocompatibility and biodegradability. Therefore, these nanocarriers could be a suitable approach for glioblastoma multiforme (GBM) therapy. The treatment of this type of tumours remains a challenge due to intrinsic resistance mechanisms. Thus, new approaches must be envisaged to target GBM tumour cells potentially providing an efficient treatment. Co-delivery of temozolomide (TMZ) and O6-benzylguanine (O6BG), an inhibitor of DNA repair, could provide good therapeutic outcomes. In this work, a fractional factorial design (FFD) was employed to produce an optimal PLGA-based nanoformulation for the co-loading of both molecules, using a reduced number of observations. The developed NPs exhibited optimal physicochemical properties for brain delivery (dimensions below 200 nm and negative zeta potential), high encapsulation efficiencies (EE) for both drugs, and showed a sustained drug release for several days. Therefore, the use of an FFD allowed for the development of a nanoformulation with optimal properties for the co-delivery of TMZ and O6BG to the brain.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 18
Documents
File name Description Size
2019_Ramalho_Pharmaceutics 4570.27 KB
Related Publications

Of the same authors

The use of nanomaterials for cancer and neurodegeneration:nanocarriers, biomembranes and immunosensors (2019)
Poster in an International Conference
Maria Ramalho; Joana A Loureiro; Manuel Coelho; Maria do Carmo Pereira
Solid Lipid Nanoparticles forGlioblastoma Multiforme therapy (2018)
Poster in an International Conference
Maria Ramalho; Stephanie Andrade; Jorge Lima; coelho, man; Joana A Loureiro; Maria do Carmo Pereira
Conjugation with anti-transferrinreceptor antibody increases PLGAnanoparticles uptake in Glioblastomacells (2018)
Summary of Presentation in an International Conference
Maria Ramalho; Jorge Lima; coelho, man; Joana A Loureiro; Maria do Carmo Pereira
Anti-transferrin receptor antibody conjugated PLGA nanoparticles for temozolomide (2017)
Summary of Presentation in an International Conference
Maria J. Ramalho; Joana A Loureiro; Jorge Lima; coelho, man; Maria do Carmo Pereira
Transferrin Receptor-Targeted Nanocarriers: Overcoming Barriers to Treat Glioblastoma (2022)
Article in International Scientific Journal
Maria J. Ramalho; Joana A Loureiro; coelho, man; Maria do Carmo Pereira

See all (10)

Of the same journal

Second-Generation Antimitotics in Cancer Clinical Trials (2021)
Another Publication in an International Scientific Journal
Novais, P; Silva, PMA; Maria Isabel Amorim; Bousbaa, H
Recent Developments in Microfluidic Technologies for Central Nervous System Targeted Studies (2020)
Another Publication in an International Scientific Journal
Teixeira, MI; Maria Helena Amaral; Paulo Costa; Lopes, CM; Lamprou, DA
Patient Centric Pharmaceutical Drug Product Design-The Impact on Medication Adherence (2020)
Another Publication in an International Scientific Journal
Menditto, E; Orlando, V; De Rosa, G; Minghetti, P; Musazzi, UM; Cahir, C; Kurczewska Michalak, M; Kardas, P; Costa, E; Sousa Lobo JM; Almeida, IF
Nanopharmaceutics: Part I-Clinical Trials Legislation and Good Manufacturing Practices (GMP) of Nanotherapeutics in the EU (2020)
Another Publication in an International Scientific Journal
Souto, EB; Silva, GF; Dias Ferreira, J; Zielinska, A; Ventura, F; Durazzo, A; Lucarini, M; Novellino, E; Santini, A
Magnetic Bone Tissue Engineering: Reviewing the Effects of Magnetic Stimulation on Bone Regeneration and Angiogenesis (2023)
Another Publication in an International Scientific Journal
Ribeiro, TP; Flores, M; Madureira, S; Zanotto, F; Fernando Mendes Monteiro; Laranjeira, MS

See all (93)

Recommend this page Top
Copyright 1996-2024 © Faculdade de Engenharia da Universidade do Porto  I Terms and Conditions  I Accessibility  I Index A-Z  I Guest Book
Page generated on: 2024-10-06 at 11:29:17 | Acceptable Use Policy | Data Protection Policy | Complaint Portal